Skip to content
Screener

Prestige Consumer Healthcare PBH Q2 2026 earnings

Reported November 6, 2025 · Before market open

Revenue$274.1MMiss by $20.0M
EPS$1.07Beat by $0.10
Revenue estimate$294.2M
EPS estimate$0.97

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$329.1M
EPS estimate$1.06

Financials

Q2 2026

Income statement

See full
Revenue$274.1M-3.4%
Gross profit$151.6M-3.7%
Operating income$79.7M-5.5%
Net income$42.2M-22.4%
EPS (diluted)$0.86-21.1%

Balance sheet

See full
Cash & equivalents$119.1M+131%
Total debt$1.0B-2.4%
Total equity$1.8B+5.4%
Total assets$3.4B+3.8%

Cash flow

See full
Operating cash flow$57.5M-17.6%
CapEx$2.1M+3.7%
Free cash flow$55.4M-18.3%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$3.07B-14.6%
Enterprise value$4B-13.4%
P/E15.3×-2.2×
P/S2.8×-0.5×

Profitability

See full
Gross margin56.1%+0.9pp
Operating margin29.9%+0.6pp
Net margin18.1%-0.5pp
FCF margin23%+0.1pp

Returns & leverage

See full
Return on equity11.3%-1.3pp
Debt / equity0.6×0.0×
Current ratio3.7×+0.1×

Segments

By product

See full
Gastrointestinal$64.2M+6.9%
Women's Health$56.2M-6.9%
Dermatologicals$35.7M-0.4%
Eye & Ear Care$34.2M-20.1%
Oral Care$24.8M+2.8%

By segment

See full
North American OTC Healthcare$230.8M-3.8%
International OTC Healthcare$43.4M-1.4%

FAQ

When did Prestige Consumer Healthcare report Q2 2026 earnings?
Prestige Consumer Healthcare (PBH) reported Q2 2026 earnings on November 6, 2025 before market open.
What were Prestige Consumer Healthcare's Q2 2026 revenue and EPS?
Prestige Consumer Healthcare reported revenue of $274.1M and eps of $1.07 for Q2 2026.
Did Prestige Consumer Healthcare beat estimates in Q2 2026?
Revenue missed the consensus estimate of $294.2M by $20.0M. EPS beat the consensus estimate of $0.97 by $0.10.
How did Prestige Consumer Healthcare's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 3.3% from $283.5M a year earlier and eps declined 1.8% from $1.09.
Where can I find Prestige Consumer Healthcare's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001295947-25-000037) and the 10-Q periodic report (0001295947-25-000039) directly on SEC EDGAR. The filing index links above go to sec.gov.